Bare Iron Oxide Nanoparticles as Drug Delivery Carrier for the Short Cationic Peptide Lasioglossin
New drug delivery systems are a potential solution for administering drugs to reduce common side effects of traditional methods, such as in cancer therapy. Iron oxide nanoparticles (IONs) can increase the drugs’ biological activity through high binding efficiency and magnetically targeted drug deliv...
Main Authors: | Chiara Turrina, Sonja Berensmeier, Sebastian P. Schwaminger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/5/405 |
Similar Items
-
Study on antibacterial activity and cytotoxicity of recombinant peptide, Lasioglossin ɪɪɪ, against foodborne pathogens
by: Mohammad B. Habibi Najafi, et al.
Published: (2018-12-01) -
Insights into the Action Mechanism of the Antimicrobial Peptide Lasioglossin III
by: Filomena Battista, et al.
Published: (2021-03-01) -
Venom Peptides Lasioglossin II and Mastoparan B as Escherichia coli ATP synthase Inhibitors
by: Bello, Rafiat Ajoke
Published: (2016) -
Dissociation and characterization of cationic radical peptides
by: Xu, Minjie, et al.
Published: (2014) -
Bare Iron Oxide Nanoparticles for Magnetic Harvesting of Microalgae: From Interaction Behavior to Process Realization
by: Paula Fraga-García, et al.
Published: (2018-05-01)